Elite Full-Body VIP Health Plan

Through physical examination of skin integrity, superficial lymph node enlargement, thyroid size/texture, breast condition, spinal and limb joint mobility, and male external genitalia; digital rectal exam for preliminary assessment of rectal status; systematically detect signs of common surgical diseases or preliminarily exclude common surgical diseases.

Through inspection, palpation, auscultation and other physical examination methods, assess the basic condition of the heart, lungs, abdomen and other organs; detect signs of common diseases or preliminarily exclude common diseases.

Assess eye appearance and visual acuity; slit-lamp examination of the eye surface and conjunctiva including lens, vitreous, cornea and conjunctiva; fundoscopy of the posterior eye including retina, optic nerve, optic disc and retinal central vessels for abnormalities.

Assess risk of glaucoma and other intraocular pressure abnormalities by measuring intraocular pressure.

Routine examination of ears, nose, pharynx and tonsils; preliminary screening for related common diseases.

Through routine blood testing, check white blood cells, red blood cells, haemoglobin, platelets and other indicators to reflect the body's condition, such as anaemia, infection, haematological diseases, physical/chemical factor injuries, etc.

Evaluate whether glucose metabolism is normal under fasting conditions; assess whether diabetic patients' fasting blood glucose control has reached the target. Fasting blood glucose is a commonly used and important indicator for evaluating glucose metabolism disorders.

HbA1c concentration effectively reflects average blood glucose over the past 8-12 weeks; used for diabetes screening and evaluation of blood glucose control.

Mainly reflects changes in blood fluidity, coagulability and blood viscosity; applicable to risk assessment of cardiovascular and cerebrovascular diseases.

A hydrolase secreted by the pancreas; indirectly indicates the presence of pancreatic infectious diseases or space-occupying lesions.

To assess liver function status and reflect indicators related to liver diseases.

Used to diagnose renal function abnormalities, gout, hyperuricaemia, etc. Serum Cystatin C is a sensitive and specific renal function indicator; an auxiliary indicator for early glomerular damage in hypertensive nephropathy, diabetic nephropathy and other conditions.

A simple and accurate method for screening urinary system diseases such as urinary tract infection, tumours and stones, and for assessing renal function; also used to assist in checking other systemic diseases such as diabetes, nephritis, etc.

Reflects the body's lipid metabolism status; helps assess cardiovascular and cerebrovascular disease risk. sdLDL-C is significantly correlated with coronary artery spasm, angina pectoris, ACS and the degree of coronary stenosis. When AI>=4 the value is abnormal - the higher the value, the more severe the arteriosclerosis and the greater the cardiovascular/cerebrovascular risk.

A sensitive indicator of tissue damage and a biomarker of cardiovascular inflammatory lesions. Plays an important role in diagnosing and predicting coronary heart disease, stroke and peripheral vascular thrombosis.

PGI, PGII and PGI/PGII ratio determination can be used for initial screening of gastric cancer, gastric ulcer and atrophic gastritis.

Used to diagnose hyperthyroidism and hypothyroidism, and for post-operative treatment monitoring of thyroid tumours; more sensitive than the thyroid function 3-item panel for diagnosing hyperthyroidism.

A positive result indicates hepatitis C virus infection; further evaluation with HCV RNA is required.

An independent risk factor for atherosclerosis and thrombosis; persistently elevated Lp(a) is closely related to angina pectoris, myocardial infarction and cerebral infarction.

Used for detecting hepatobiliary diseases, differential diagnosis of jaundice, bone diseases, etc.

Has important clinical significance for the diagnosis, treatment monitoring and prognosis evaluation of primary liver cancer; also supports auxiliary assessment of gastric, pancreatic and testicular cancers, hepatitis and liver cirrhosis.

A broad-spectrum tumour marker with important clinical significance for colorectal and pancreatic cancer screening, treatment monitoring and prognosis evaluation; may also be elevated in gastric, breast and lung cancers.

Important for pancreatic, biliary and gastrointestinal cancer screening, treatment monitoring and prognosis evaluation; may also be elevated in acute pancreatitis, cholangitis, cholelithiasis, acute hepatitis and liver cirrhosis.

In prostatitis and prostatic hyperplasia, t-PSA is mildly elevated; when both t-PSA and f-PSA are elevated with a decreased f-PSA/t-PSA ratio, prostate cancer may be indicated.

In prostatitis and prostatic hyperplasia, t-PSA is mildly elevated; when both t-PSA and f-PSA are elevated with a decreased f-PSA/t-PSA ratio, prostate cancer may be indicated.

Important for early diagnosis and prognosis evaluation of small-cell lung cancer and neuroblastoma.

Assists in initial screening of squamous cell-origin tumours; an auxiliary indicator for lung squamous cell carcinoma and oesophageal cancer diagnosis, disease monitoring and prognosis.

Important for early diagnosis, treatment monitoring and prognosis of non-small-cell lung cancer.

A tumour marker for auxiliary diagnosis of pancreatic and colorectal cancers.

A tumour-associated glycoprotein used for auxiliary diagnosis of gastrointestinal tumours; combined with CEA, it improves the sensitivity and specificity of gastric cancer assessment.

Used for early auxiliary diagnosis of nasopharyngeal carcinoma.

Colour ultrasound imaging of the liver, gallbladder, pancreas and spleen to detect any morphological changes or space-occupying lesions (tumours, stones, inflammation, etc.).

Colour ultrasound imaging of bilateral kidneys to detect any morphological changes or space-occupying lesions (tumours, stones, inflammation, etc.).

Colour ultrasound of the thyroid to detect any morphological changes or space-occupying lesions (enlargement, nodules, adenomas, tumours, etc.).

Colour ultrasound to detect atherosclerosis and carotid artery conditions.

Screening for abdominal aortic aneurysm and atherosclerotic plaques.

Colour ultrasound dynamically displays cardiac chamber structure, cardiac pulsation and valvular blood flow; an important tool for diagnosing various heart diseases.

Colour ultrasound to detect prostatic masses and other lesions.

Head MRI directly displays cranial nerves and detects early neural lesions; no skull artefacts and high grey-white matter signal contrast make it significantly superior to CT.

Examines the liver, gallbladder, pancreas and spleen; MRI has high soft-tissue resolution and is valuable for differential diagnosis of liver and pancreatic lesions, showing perilesional invasion and metastasis. Liver fat quantification measures fat content and iron-related parameters.

Low-dose spiral CT (LDCT) optimises tube current, voltage and pitch to reduce radiation dose to about 20% of conventional chest CT. LDCT helps detect early lung cancer - pulmonary tumours of approximately 0.5 cm can be clearly imaged, especially peripheral lung cancer, with a detection rate about 10 times that of chest X-ray. The lower radiation dose effectively reduces the risk of iatrogenic radiation-induced malignancy.

The coronary artery calcium score is a quantitative indicator for assessing the degree of coronary artery calcification; a reference factor for predicting coronary heart disease risk.

Through measurement of four-limb blood pressure and related calculations, early determination of arteriosclerosis, lower-limb arterial stenosis/occlusion and varicose veins; also assists in checking peripheral vascular thrombosis.

Uses low-frequency pulsed waves to objectively evaluate haemodynamic changes in the basal arteries, internal carotid arteries and external carotid arteries caused by intracranial arterial changes (stenosis, occlusion, vascular malformations, etc.).

Through ultrasound transmission rate, detects bone density of the lower-limb ankle; evaluates bone mass and possible osteoporosis.

Through synchronous recording and analysis of the electrical activity curve of each cardiac cycle at specific body surface locations; provides an important basis for cardiac disease diagnosis, treatment evaluation and prognosis assessment.